Abstract:Objective To evaluate the long-term clinical efficacy and toxicities of combined intracavitary hyperthermia and radiotherapy fur locally advanced uterine cervical cancer. Methods 310 patients with locally advanced uterine cervical cancer were assigned into intracavitary hyperthermia + radiotherapy group(TRT, 181 patients) and external-beam radiotherapy + traditional intracavitary radiation group (RT,129 patients). The external-beam radiotherapy were given with 60Co γ-my or 6-8 MV X-ray in traditional fractionation. In TRT group,radiotherapy was 40 Gy using the anterior-posterior pelvic fields and additional 20-25 Gy using the lateral fields. Hyperthermia was delivered by the 915 MHz microwave hyperthermia device within 15-60 min after external radiotherapy for 10-12 times(40 min each time,1-2 times per week). The temperature of tumor surface was 46-47℃. In the RT group, the external-beam radiotherapy of 40 Gy was delivered using the anterior-posterior pelvic fields. The intracavity radiotherapy of radium was delivered before 1989 ,with 50 mg radium in the vagina and 30 mg in uterine cavity for 24 hours ,weekly for 3 times to a total dose of 7200 mg·h. After 1989,intraeavity radiotherapy of 192Ir was delivered to a total dose of 30-36 Gy to point A in 5-6 Gy fractions,2 fractions per week. Results The 5-year survival of patients in TRT group and RT group was 67.4% versus 52.1% for stage Ⅱ disease (χ2=7.55,P=0.006), and 60.0% vemus32.3% forstage Ⅲ (χ2=7.06,P=0.007) . The 10-year survival was46.5% versus42.6% for stage Ⅱ (χ2=3.90,P=0.058), and 43.7% versus 20.6% for stage Ⅲ(χ2=17.28,P=0.000). Cox regression analysis showed that the tumor stage(P=0.023) and intracavitary hyperthermia( P=0.019) were prognostic factors. According to the RTOG criteria, the rate of mild to moderate late side effects of rectum and bladder in TRT and RT group was 17.7% and 33.1%, respectively (χ2=9.18, P=0.002). Rectovaginal fistula was developed in5 patients(3.9% ) in RT group and I patient (0.6%) in TRT group(χ2= 4.38,P=0.036). Conclusions The long-term survival of patients with stage Ⅲ uterine cervical cancer is better of TRT group than RT group. The TRT is well tolerated and the late toxicity rate is obviously low. It is necessary to carry out large randomized clinical trials to confirm these outcomes.

Efficiency of Deep Hyperthermia Combined with Concurrent Chemo-Radiotherapy in the Advanced Cervical Cancer

The Efficacy Analysis of 61 Cases of Advanced Cervical Microwave Hyperthermia Combined with Concurrent Chemoradiotherapy

Outcomes for Hyperthermia Combined with Concurrent Radiochemotherapy for Patients with Cervical Cancer

Short-term efficacy of intracavitary radiotherapy combined with hyperthermia after concurrent chemoradiotherapy in the treatment of locally advanced cervical cancer

Hyperthermia combined with chemotherapy and radiotherapy in the treatment of 42 patients with advanced non-small cell lung cancers

Docetaxel combined with intraperitoneal hyperthermic perfusion chemotherapy and hyperthermia to cure advanced ovarian cancer

Long-term outcomes of intracavitary hyperthermia in combination with radiotherapy for locally advanced uterine cervical cancer

The Efficacy of Volumetric Modulated Arc Therapy Combined with Chemotherapy, Brachytherapy, and Local Hyperthermia on Patients with Locally Advanced Cervical Cancer: A Retrospective Study

[Hyperthermia Combined with Chemotherapy in the Treatment of Advanced Non-Small Cell Lung Cancer: an Initial Study].

Study on the effect of chemoradiotherapy combined with deep hyperthermia in the treatment of thoracic esophageal cancer

The Efficacy of Radiofrequency Hyperthermia Combined with Chemotherapy in the Treatment of Advanced Ovarian Cancer

Study of high power microwave hyperthermia combined with chemotherapy in the treatment of patients with advanced cancer

High Power Microwave-Based Whole Body Hyperthermia Combined with Chemotherapy for Advanced Tumor

Therapeutic Effect of Whole Body Hyperthermia Combined with Chemotherapy in Patients with Advanced Cancer

Radiotheraphy with Concurrent Chemotherapy for Treatment of Medium-term and Advanced Cervical Cancer

The Study of Concurrent Chemoradiotherapy in Medium-Term and Advanced Cervical Carcinoma the Uterine Cer-Vix

Curative Effect of Synchronous Radiochemotherapy in Medium-term and Advanced Cervical Carcinoma

HCRT for Adva nced Cervical Carcinoma:A Meta-analysis

Radiotherapy and Hyperthermia for Metaphase or Advanced Non-Small-cell Lung Cancer

Deep regional hyperthermia combined with modern concurrent chemoradiotherapy increases T-downstaging rate in locally advanced rectal cancer

[Extended-Field Intensity Modulated Radiation Therapy and Intra-Cavitary Brachytherapy Combined with Chemotherapy for Stage Ib1-IVa Cervical Cancer with Positive Para-Aortic Lymph Nodes].